Fungal biomarker discovery by integration of classifiers

João Pedro Saraiva1,2, Marcus Oswald1,2, Antje Biering1,2

  • 1Network Modelling, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute (HKI), Beutenbergstraße 11a, Jena, Germany.

BMC Genomics
|August 12, 2017
PubMed
Abstract

Insights

This study developed a gene signature to differentiate fungal and bacterial infections, improving diagnostic accuracy. The method combines classifiers for reliable identification of infection types, crucial for timely treatment.

Area of Science:

  • Immunology
  • Computational Biology
  • Infectious Diseases

Background:

  • The human immune system protects against infection, but immunocompromised individuals face increased risks.
  • Systemic infections like sepsis, caused by bacteria and fungi, lead to significant mortality.
  • Rapidly discriminating between fungal and bacterial pathogens is critical for appropriate treatment with antifungals or antibiotics.

Purpose of the Study:

  • To develop a reliable gene signature for distinguishing between fungal and bacterial infections.
  • To overcome limitations of previous studies yielding heterogeneous results due to experimental variations.

Main Methods:

  • Employed Mixed Integer Linear Programming (MILP) based classifiers on multiple datasets.
  • Combined independent classifiers through joint optimization to enhance biomarker gene list consistency.

Main Results:

  • Achieved a 43% increase in pairwise overlap for biomarker gene lists compared to single classifiers.
  • Identified a refined 19-gene signature, with most genes linked to the ERK-MAPK signaling pathway.
  • Validated the signature on an unseen dataset, achieving an average accuracy of 83%.

Conclusions:

  • The developed method effectively combines independent classifiers to improve gene signature consistency and reliability.
  • This approach offers a more robust tool for differentiating between fungal and bacterial infections.